Takizawa, Jun http://orcid.org/0009-0000-7125-3927
Suzuki, Ritsuro
Izutsu, Koji
Kiguchi, Toru
Asaoku, Hideki
Saburi, Yoshio
Masunari, Taro
Utsunomiya, Atae
Takeuchi, Kengo
Nakamura, Naoya
Ohshima, Koichi
Gruber, Michaela
Jäger, Ulrich
Aoki, Sadao
Suzumiya, Junji
Funding for this research was provided by:
Japan Society for the Promotion of Science (16K08963, 19K07863, 23K06848)
Article History
Received: 19 November 2023
Revised: 20 February 2024
Accepted: 27 February 2024
First Online: 16 March 2024
Declarations
:
: Jun Takizawa: Honoraria from AstraZeneca, AbbVie, Janssen, Novartis, Chugai, Kyowa-Kirin, Ono, Eisai, Nippon Kayaku; research funding from AstraZeneca, AbbVie, Janssen, Novartis, Chugai, Yakult, Kyowa-Kirin, Ono, Eisai, Nippon Shinyaku, Asahi Kasei, Nippon Kayaku. Ritsuro Suzuki: Chugai, Kyowa-Kirin, Abbvie, Bristol-Meyer Squib, Eisai, MSD, Janssen, Takeda, Meiji-Seika, Ohtsuka, Novartis, AstraZeneca; research funding from Chugai, Kyowa-Kirin, Shionogi, Taiho, Ohtsuka. Koji Izutsu: Honoraria from Bristol Myers Squibb, AstraZeneca, Janssen, Eisai, Kyowa-Kirin, Takeda, Chugai, Novartis, MSD, Symbio, AbbVie, Ono, Pfizer, Eli lily, Daiichi Sankyo; consulting role for Bristol Myers Squibb, AstraZeneca, Zenyaku, MSD, Nippon Shinyaku, AbbVie, Ono, Genmab, Mitsubishi Tanabe Pharma, Nippon Kayaku; research funding from MSD, AstraZeneca, AbbVie, Eisai, Incyte, Bristol Myers Squibb, Novartis, Pfizer, Janssen, Yakult, Kyowa-Kirin, Ono, Daiichi Sankyo, Chugai, Beigene, LOXO Oncology, Otsuka, Regeneron. Toru Kiguchi: Honoraria from Bristol-Meyer Squib, Astellas, Novartis, Nippon Shinyaku, Symbio, AbbVie; consulting role for Astellas. Atae Utsunomiya: Honoraria from Meiji-Seika, Kyowa-Kirin, Bristol-Meyer Squib; consulting role for JIMRO, HUYA Japan, Otsuka Medical Devices. Kengo Takeuchi: Honoraria from Eli Lilly, Chugai, Kyowa-Kirin, Janssen; research funding from Fujirebio, SONY, Daiichi Sankyo; consulting role for Nichirei Bioscience, Nippon Shinyaku, Meiji-Seika; Royalties or licenses from Sysmex, AMOY, Nichirei Bioscience. Ulrich Jäger: Honoraria from Roche, Abbvie, Janssen, Beigene, Novartis, and BMS; consulting role for Roche. Sadao Aoki: Honoraria from AstraZeneca, Janssen. Junji Suzumiya: Honoraria from Abbvie, AstraZeneca, Bristol Myers Squibb, Chugai, Dainihon-Sumitomo, Eli Lill, Janssen, Kyowa-Kirin, Novartis, Ootsuka, SymBio, Takeda, Zenyaku, Tanabe-Mitsubishi; consulting role for Abbvie, Chugai, Janssen, Kyowa-Kirin, Nippon Shinyaku, Ootsuka, SymBio, Zenyaku. The other authors have no conflict of interest.
: This study was approved by the Institutional Review Board of Shimane University (#2805) and all participating institutions.
: Written informed consent was obtained from all subjects enrolled in the study.